Cdc7-IN-7
Product Specifications
UNSPSC Description
Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-7.html
Solubility
10 mM in DMSO
Smiles
O=C(C(C/1=O)=C(NN2CCOCC2)OC1=C/C3=CNC4=NC=CC=C43)OCC5CC5
Molecular Weight
410.42
References & Citations
[1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-130519/Cdc7-IN-7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-130519/
Clinical Information
No Development Reported
CAS Number
1402059-17-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items